The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Glaxosmithkline Pharmaceuticals Ltd. Share Price
Pharmaceuticals & DrugsGlaxosmithkline Pharmaceuticals Ltd. (INR)3286.432.4 (1%) 
Exchange ScripsBSE500660NSEGLAXOISININE159A01016
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Glaxosmithkline Pharmaceuticals Ltd. Performance
Market performance
Open price3240.1
High3306.7
Volumes151746
Prev Close3286.4
Low3240.1
Closing date2025-06-18
Historical performance
1 Year High3515.70
3 Year High3515.70
5 Year High3515.70
1 Year Low1921.00
3 Year Low1227.00
5 Year Low1227.00
Glaxosmithkline Pharmaceuticals Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Glaxosmithkline Pharmaceuticals Ltd. Investment Returns
1 Year
24.3%
3 Years
116.1%
5 Years
139.6%
10 Years
98.4%
Glaxosmithkline Pharmaceuticals Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 3304.44 | Bearish |
| 10-DMA | 3360.12 | Bearish |
| 20-DMA | 3278.29 | Bullish |
| 50-DMA | 3005.64 | Bullish |
| 100-DMA | 2727.43 | Bullish |
| 200-DMA | 2620.31 | Bullish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | 4 | 4 | 4 | 4 | 4 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 121881 | 119621 | 119224 | 118511 | 118990 |
| Government | 3 | 3 | 2 | 2 | 2 |
Glaxosmithkline Pharmaceuticals Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
| Other Income | 1459 | 1226 | 1007 | 758 |
| Operating Profit | 13233 | 10313 | 9049 | 8377 |
| Interest | 13 | 18 | 18 | 20 |
| Depreciation | 668 | 697 | 658 | 682 |
| Profit Before Tax | 12599 | 8162 | 8364 | 7790 |
| Consolidated Net Profit | 9276 | 5900 | 6107 | 16947 |
| Adjusted EPS | 55 | 35 | 36 | 100 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
| Share Capital | 1694 | 1694 | 1694 | 1694 |
| Total Reserves | 17968 | 16172 | 15735 | 24936 |
| Minority Interest | --- | --- | --- | --- |
| Total Non-Current Liabilities | 1107 | 1077 | 1254 | 1587 |
| Total Liabilities | 39672 | 34103 | 31930 | 45201 |
| Capital Work in Progress | 143 | 139 | 203 | 305 |
| Total Assets | 39672 | 34103 | 31930 | 45201 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 12899 | 5820 | 4842 | 8107 |
| Cash Flow from Investing Activities | -458 | 87 | 8079 | -4055 |
| Cash Flow from Financing Activitie | -7694 | -5615 | -15433 | -5242 |
| Net Cash Inflow / Outflow | 4747 | 292 | -2512 | -1190 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 60.02.
- 3Y Stock Price CAGR of the stock is 29.6.
- The stock has a beta of 0.6.
- In the last financial year, the company had an EBITDA of ₹13233 Million.
- The company generated revenue of ₹37492 Million in the previous financial year.
Glaxosmithkline Pharmaceuticals Ltd.
3286.432.4 (1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1281972.3
No. of Shares: 390.1
Performance:28.2%
P/L: ₹281972.3
Top Gainers
| Symbol | Change% |
|---|---|
| EMIL | 158.37(18%) |
| SILLYMONKS | 18(14%) |
| OPTIEMUS | 684.6(11%) |
| AAKASH | 9.7(11%) |
| PFOCUS | 130.98(10%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent